To determine the relationship between CALCRL expression levels and the clinical features or prognosis of AML patients, 67 primary AML/ETO+ AML patients were enrolled, including 40 men and 27 women, with a median age of 35 (range, 15–57) years. Here, RUNX1T1 is linked to acute myeloid leukemia.